11,390
Total Claims
$2.1M
Drug Cost
2,336
Beneficiaries
$901
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-23%
Cost per patient vs peers
$901 vs $1,174 avg
+60%
Brand preference vs peers
14.2% vs 8.9% avg
Brand vs Generic
86% generic
Brand: 1,620 claims · $1.8M
Generic: 9,770 claims · $323K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 586 | $696K |
| Sacubitril/Valsartan | 283 | $356K |
| Rivaroxaban | 165 | $220K |
| Empagliflozin | 108 | $127K |
| Dapagliflozin Propanediol | 90 | $117K |
| Evolocumab | 99 | $115K |
| Ticagrelor | 58 | $47K |
| Dronedarone Hcl | 25 | $40K |
| Metoprolol Succinate | 1,369 | $38K |
| Icosapent Ethyl | 51 | $32K |
| Rosuvastatin Calcium | 581 | $24K |
| Ezetimibe | 425 | $23K |
| Atorvastatin Calcium | 955 | $22K |
| Ranolazine | 130 | $20K |
| Icosapent Ethyl | 28 | $15K |
Prescribing Profile
64
Unique Drugs
$1.5M
Patient Profile
75
Avg Age
46%
Female
1.71
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data